Efficacy and Safety of SYNB1934 in Patients With PKU (SYNPHENY-3)
Trial details
- Registry ID
- NCT05764239
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Efficacy and Safety of SYNB1934 in Patients With PKU (SYNPHENY-3)NCT05764239 | Synlogic | Phase 3 | Terminated | 2024-03-15Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |